INTERVENE-HF: feasibility study of individualized, risk stratification-based, medication intervention in patients with heart failure with reduced ejection fraction.

Michael R ZileMaria Rosa R CostanzoEkaterina M IppolitoYan ZhangRussell StapletonAshish SadhuJavier JimenezJoe HobbsVinod SharmaEduardo N WarmanLindsay StreeterJaved Butler

Published in: ESC heart failure (2021)

The Intervene-HF study supports the feasibility of testing, in a large randomized clinical trial, an ambulatory medication intervention strategy that is physician-directed, CHFN-implemented, and based on individualized device risk stratification.

Keyphrases

randomized controlled trial
healthcare
blood pressure
emergency department
primary care
adverse drug
acute heart failure
clinical trial
heart failure
atrial fibrillation